The University of Queensland

Preclinical development of combinations with CHK1 inhibitors in melanoma and lung cancer (2018–2019)

Grant type:

Cancer Council Queensland

Researchers:

• 

  Professor Brian Gabrielli

  Honorary Professor
  

  Mater Research Institute-UQ

  Faculty of Medicine

Funded by:

Cancer Council Queensland